Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Bullboard Posts
Comment by Tweedledeon Aug 24, 2018 11:38am
153 Views
Post# 28512402

RE:2ND Q Results and Thoughts

RE:2ND Q Results and Thoughts
Insightful1 wrote: On the large expense side of the release, I dug a little deeper and two items that need addressing 1) the platform build is a one-time cost of some $371,000 which will produce millions of dollars of revenue for the foreseeable future and a ridiculous accounting item which is the option pricing model. This is the Black  Scholes model that is very inaccurate for pricing with smallcap companies because of the volatility premium assigned to shares that have experienced large price fluctuation. This is a theoretical number and does not in any way affect cash flow or real operational revenue. But it represented almost 1 million dollars.
It may not effect cash reserves, but it does takes a hit to the company valuation. 1M in options expenses, and 370k in development expenses.. hmm... seems a little rich to me.
Bullboard Posts